Cargando…

Association Between Use of Warfarin for Atrial Fibrillation and Outcomes Among Patients With End-Stage Renal Disease: A Systematic Review and Meta-analysis

IMPORTANCE: Several studies have examined the role of warfarin in preventing strokes in patients with atrial fibrillation and end-stage renal disease; however, the results remain inconclusive. OBJECTIVE: To assess recently published studies to examine the outcomes of the use of warfarin among patien...

Descripción completa

Detalles Bibliográficos
Autores principales:	Randhawa, Mandeep S., Vishwanath, Rohanlal, Rai, Manoj P., Wang, Ling, Randhawa, Amritpal K., Abela, George, Dhar, Gaurav
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Medical Association 2020
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7136833/ https://www.ncbi.nlm.nih.gov/pubmed/32250434 http://dx.doi.org/10.1001/jamanetworkopen.2020.2175

Ejemplares similares

Atrial fibrillation bleeding risk and prediction while treated with direct oral anticoagulants in warfarin‐naïve or warfarin‐experienced patients
por: Perino, Alexander C., et al.
Publicado: (2022)

Examining warfarin underutilization rates in patients with atrial fibrillation: Detailed chart review essential to capture contraindications to warfarin therapy
por: Srivastava, Ajay, et al.
Publicado: (2008)

Switching warfarin to direct oral anticoagulants in atrial fibrillation: Insights from the NCDR PINNACLE registry
por: Sciria, Christopher T., et al.
Publicado: (2020)

Warfarin and atrial fibrillation: from ideal to real the warfarin affaire
por: Molteni, Mauro, et al.
Publicado: (2014)

Warfarin use and stroke, bleeding and mortality risk in patients with end stage renal disease and atrial fibrillation: a systematic review and meta-analysis
por: Tan, Jingwen, et al.
Publicado: (2016)

Thromboembolism, bleeding and vascular death in nonvalvular atrial fibrillation patients with type 2 diabetes receiving rivaroxaban or warfarin
por: Coleman, Craig I., et al.
Publicado: (2021)

Impact of stated barriers on proposed warfarin prescription for atrial fibrillation: a survey of Canadian physicians
por: Nicholls, Stuart G, et al.
Publicado: (2014)

Atrial fibrillation in advanced renal failure: are there alternative solutions to warfarin-dicumarol?
por: Rossini, Roberta, et al.
Publicado: (2021)

The use of warfarin in veterans with atrial fibrillation
por: Bravata, Dawn M, et al.
Publicado: (2004)

Stroke Prophylaxis in Patients with Atrial Fibrillation and End-Stage Renal Disease
por: van Zyl, Martin, et al.
Publicado: (2020)

Atrial fibrillation, end-stage renal disease and hemorrhagic pleural-pericarditis
por: Leonte, Raluca-Mihaela, et al.
Publicado: (2021)

Comparison of health-related quality of life among patients using novel oral anticoagulants or warfarin for non-valvular atrial fibrillation
por: Balcı, Kevser Gülcihan, et al.
Publicado: (2016)

Effectiveness and safety of rivaroxaban versus warfarin in Taiwanese patients with end-stage renal disease and nonvalvular atrial fibrillation: A real-world nationwide cohort study
por: Lin, Yi-Cheng, et al.
Publicado: (2021)

Safety and Efficacy of Apixaban versus warfarin in patients with atrial fibrillation or Venous Thromboembolism and End-Stage renal disease on hemodialysis: A systematic review and meta-analysis
por: Murtaza, Ghulam, et al.
Publicado: (2021)

Treatment with direct oral anticoagulants or warfarin and the risk for incident diabetes among patients with atrial fibrillation: a population‐based cohort study
por: Cheung, Ching-Lung, et al.
Publicado: (2021)

Atrial fibrillation ablation in end-stage renal Disease:...Yes, we can!
por: Kowlgi, Gurukripa N., et al.
Publicado: (2021)

Efficacy and safety of apixaban vs warfarin in patients with atrial fibrillation and prior bioprosthetic valve replacement or valve repair: Insights from the ARISTOTLE trial
por: Guimarães, Patricia O., et al.
Publicado: (2019)

Patients’ time in therapeutic range on warfarin among atrial fibrillation patients in Warfarin Medication Therapy Adherence Clinic
por: Lee, Siew Ling, et al.
Publicado: (2021)

Warfarin slows deterioration of renal function in elderly patients with chronic kidney disease and atrial fibrillation
por: Chang, Chia-Chu, et al.
Publicado: (2013)

Whether Warfarin Therapy is Associated with Damage on Renal Function in Chinese Patients with Nonvalvular Atrial Fibrillation
por: Kong, Yu, et al.
Publicado: (2016)

Real-world Experience in Managing Atrial Fibrillation in Patients with Renal Impairment; Rivaroxaban versus Warfarin
por: Albabtain, Monirah Abdulrahman, et al.
Publicado: (2023)

Anticoagulation in Patients with End-Stage Renal Disease and Atrial Fibrillation: Confusion, Concerns and Consequences
por: Goel, Narender, et al.
Publicado: (2020)

Blood pressure status affects atrial fibrillation in diabetic end-stage renal disease
por: Han, Kyung-Do, et al.
Publicado: (2023)

Recent advances in antibacterial drugs
por: Rai, Jaswant, et al.
Publicado: (2013)

Inequalities and outcomes: end stage kidney disease in ethnic minorities
por: Wilkinson, Emma, et al.
Publicado: (2019)

Initiation and Persistence with Warfarin Therapy in Atrial Fibrillation According to Ethnicity
por: Hansen, Carolina Malta, et al.
Publicado: (2012)

Improving outpatient warfarin use for hospitalized patients with atrial fibrillation
por: Touchette, Daniel R., et al.
Publicado: (2008)

Dabigatran Versus Warfarin for Direct Current Cardioversion in Atrial Fibrillation
por: Benamer, Sufyan, et al.
Publicado: (2016)

Effect of apixaban compared with warfarin on coagulation markers in atrial fibrillation
por: Christersson, Christina, et al.
Publicado: (2019)

NOACs vs. Warfarin for Stroke Prevention in Nonvalvular Atrial Fibrillation
por: Patel, Priya, et al.
Publicado: (2017)

Characteristics of warfarin under-prescription in older adults with atrial fibrillation
por: Rashid, Sana, et al.
Publicado: (2021)

Is this the beginning of end for warfarin in bioprosthetic mitral valve recipients with atrial fibrillation? – New insights from RIVER trial
por: Sahu, Ankit Kumar, et al.
Publicado: (2021)

Association of Early-Stage Breast Cancer and Subsequent Chemotherapy With Risk of Atrial Fibrillation
por: Abdel-Qadir, Husam, et al.
Publicado: (2019)

Apixaban successfully resolved a warfarin-resistant left atrial appendage thrombus in a patient with end-stage renal disease on hemodialysis
por: Park, Yae Min, et al.
Publicado: (2019)

Renal artery embolism successfully managed by ultrasound enhanced catheter directed thrombolysis
por: Hassanein, Mohamed, et al.
Publicado: (2018)

Warfarin doses for anticoagulation therapy in elderly patients with chronic atrial fibrillation
por: de Padua Mansur, Antonio, et al.
Publicado: (2012)

Cost-Effectiveness of Apixaban Compared with Warfarin for Stroke Prevention in Atrial Fibrillation
por: Lee, Soyon, et al.
Publicado: (2012)

Warfarin use in hemodialysis patients with atrial fibrillation: decisions based on uncertainty
por: Juma, Salima, et al.
Publicado: (2013)

Survey of the use of warfarin and the newer anticoagulant dabigatran in patients with atrial fibrillation
por: Choi, Jiyoon C, et al.
Publicado: (2014)

The Association Between Bleeding and the Incidence of Warfarin Discontinuation in Patients with Atrial Fibrillation
por: Simon, Teresa A., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_kgq1j7oicfc873m2sq339crld2